Is The Viral 'Quad-demic' Still Swirling? Know The Good, Bad And Ugly

Updated Feb 7, 2025 | 01:00 AM IST

SummaryFlu, COVID-19, RSV, and norovirus are spreading at high levels in the U.S., causing overlapping symptoms like fever, fatigue, and nausea. Are early testing and vaccination enough to preventing severe infections with overlapping symptoms?
Is The Viral 'Quad-demic' Still Swirling? Know The Good, Bad And Ugly

Image Credit: Health and me

There's been an alarming increase of respiratory and gastrointestinal viruses in the United States lately, causing anxiety about a so-called "quad-demic". According to surveillance reports, influenza, COVID-19, RSV and norovirus are at very high levels everywhere. While the surge aligns with patterns typical for this season, several epidemiologists view simultaneous infections of such proportions to pose risks not only to individual healthcare but public health.

The incidence of the quad-demic should vary with seasonal patterns, vaccination rates, and public health interventions. Each virus alone is relatively easy to manage; however, the effect of all together could lead to overburdening of health care facilities and increase risks for those at higher risk. Continuing surveillance, early testing, and proactive prevention measures will play an important role in the control of these infections going forward.

While the term "quad-demic" sounds daunting, it must be taken into perspective. For years, we have had all these viruses together, and we have the capabilities to mitigate some of the risk. Vaccination, proper hygiene and using common sense helps individuals get through the season unscathed. Is the quad-demic a permanent fixture or just another seasonal wave? Let's break this down.

What is the Quad-demic?

Typically, flu, COVID-19, and RSV have been the primary culprits behind seasonal respiratory infections. However, norovirus, a highly contagious stomach bug, has emerged as a fourth significant player, inducing fears of a more severe and widespread viral outbreak. According to the Centers for Disease Control and Prevention (CDC), the U.S. recorded nearly 500 norovirus outbreaks between August and December 2023, a substantial rise from the previous year’s numbers.

While the term "quad-demic" may sound ominous, the seriousness and consequences of such infections should be weighed in light of the U.S. healthcare system's experience with managing viral surges since the start of the COVID-19 pandemic.

1. Influenza (Flu)

Flu continues to be one of the most common and alarming seasonal illnesses. In the period spanning from 2023 to 2024, there were approximately 40 million cases of flu, and thousands of hospitalizations along with reported 47 deaths have been reported this season. Flu symptoms include fever, chills, cough, sore throat, muscle pain, and fatigue, with most recovering within a week or two but risky factors for severe illness effects occur in young children, elderly, and people with chronic conditions.

2. Covid-19

Despite its reduction from the first pandemic peak, COVID-19 is still rampant. The CDC estimates that alone between October and December 2023, there were between 2.7 and 5 million cases in the U.S. Hospitalization has increased by cities such as Los Angeles, Chicago, and New York. Symptoms are closely similar to the flu, fever, cough, and fatigue but uniquely presents in some cases as loss of taste and smell.

3. RSV

RSV is the most common cause of lower respiratory infections in infants, older adults, and immunocompromised individuals. While RSV peaked late in 2023 and early 2024, it continues to be a threat because it can lead to bronchiolitis and pneumonia. It is very similar to the common cold, presenting with symptoms such as congestion, runny nose, coughing, and fever, which can make it difficult to differentiate from flu or COVID-19 without testing.

4. Norovirus

Norovirus, also called the "stomach flu," is a highly contagious infection of the gastrointestinal tract, not a respiratory virus. It transmits quickly from contaminated food and water and contact with contaminated surfaces, causing such symptoms as diarrhea, vomiting, nausea, and stomach pain. Cases have shot up, the CDC said Monday, with reports of outbreaks surging compared with last year.

Is There a Challenge In Diagnosis Due to Overlapping Symptoms?

The greatest challenge during the quad-demic is how the four viruses are alike and thus make identification very hard with no testing applied. Most cases present symptoms common to all viruses: fever, tiredness, body pains, and respiratory, which includes coughing and congestions for influenza, COVID-19, and RSV; the other would be norovirus symptoms as nausea and vomiting can appear even in extreme influenza and COVID-19. This overlap increases the risk of misdiagnosis and delayed treatment, hence the need for early testing and proper medical guidance.

Also Read: Is US Preparing For A Quad- demic 2025?

Effective Prevention Strategies That Work

The best defense against these viruses is a combination of vaccines, hygiene, and lifestyle precautions. While lifestyle modifications are highlighted as part of the constant need to eat healthy, ensure daily movement and drinking adequate amount of fluids. There is a sure short two preventive strategies that are effective:

Vaccination

  • Flu vaccine: Annual flu shots reduce the severity of infection, allergic flare ups and hospitalizations.
  • COVID-19 vaccine: Though COVID-19 cases have declined, vaccination remains critical in preventing severe outcomes.
  • RSV vaccine: Available for those aged 60 years and older, especially those with underlying conditions.
  • Norovirus vaccine: No vaccine is yet available, but mRNA vaccine research is in progress.

Hygiene and Sanitation

  • Washing hands frequently with soap and water for at least 20 seconds, especially after public exposure.
  • Disinfect frequently touched surfaces regularly, use sanitiser when outside.
  • Avoid close contact with infected people and wear masks.

Do You Need To Wear A Mask All The Time?

While debates on masked wear continue on, experts on mask-wear affirm that this does not only have a historical precedent but works towards reducing airborne viruses spreading within the environments. Hospitals, though, ensure masking in key sections of themselves. Publicized mask-wear remains a discretion, though massing indoors still goes a longer way in cases like peak flu seasons.

If you notice the symptoms of these viruses, then it's best to be confined at home and avoid having face-to-face interaction with others and seek immediate attention from your physician if your condition worsens. Quarantining for some days can decrease the spread of infection.

As we move into the first half of 2025 and beyond, staying informed and proactive is the best strategy for maintaining health and avoiding unnecessary panic. The key takeaway? Stay vigilant, but don’t be alarmed—these viruses are here, but so are the means to fight them.

End of Article

Travel Vaccine Update: CDC Issues Travel Advisory Against 32 Countries For Poliovirus

Updated Mar 13, 2026 | 01:16 PM IST

SummaryThe CDC issued a Level 2 travel advisory for 32 countries where poliovirus is circulating, urging travelers to stay updated on polio vaccines and get booster shots to reduce the risk of infection.
Travel Vaccine Update: CDC Issues Travel Advisory Against 32 Countries For Poliovirus

Credits: Canva

On March 9, the United States issues a travel advisory against global polio and listed 32 countries, including some European countries. The International travel often comes with vaccine reminder and health checks to stay safe. The Centers for Disease Control and Prevention (CDC) issued a Level 2 travel advisory for certain international destinations with circulating poliovirus. The CDC has asked travelers to ensure they are up to date on their polio vaccines.

Also Read: Harish Rana Case Brings Spotlight On How Passive Euthanasia Has Evolved Over The Years

The Destination list for global polio travel Advisory notice includes:

  • Afghanistan
  • Algeria
  • Angola
  • Benin
  • Burkina Faso
  • Cameroon
  • Central African Republic
  • Chad
  • Côte d'Ivoire
  • Democratic Republic of the Congo
  • Djibouti
  • Ethiopia
  • Gaza
  • Germany
  • Guinea
  • Israel
  • Laos
  • Namibia
  • Niger
  • Nigeria
  • Pakistan
  • Papua New Guinea
  • Poland
  • Senegal
  • Somalia
  • South Sudan
  • Sudan
  • Tanzania
  • United Kingdom
  • Yemen

The CDC issued a 'Level 2' advisory, which means to 'practice enhanced precautions'.

The advisory suggests that children and adults should be up to date on their routine polio vaccines. Travelers are also asked to get an inactivated polio vaccine booster if they are going to the destination that has circulating poliovirus, or have completed their routine polio vaccine series; and have not already received one adult booster dose.

Also Read: Colon Cancer Is The Leading Cause Of Death In US For People Under 50

If Polio Has Been Eliminated In The US, Then Why Do Travelers Need Advisory?

Dr Leana Wen, CNN wellness expert, who is an emergency physician and adjunct associate professor at the George Washington University said that while the US eliminated continuous transmission of polio in 1979, eradication within the country does not eliminate the risk when people travel to places where the virus is still circulating.

Speaking to CNN, Wen said that the risk for any individual traveler is usually low if they are fully vaccinated, however, from a population health perspective, it is important to take the precautionary steps. "Even a single imported case could lead to local spread in communities where vaccination coverage is low."

Types Of Notices Issued By CDC

The CDC issues four different types of notices based on the gravity of the disease spread.

Level 1 : Practice Usual Precautions

Practice usual precautions for this destination, as described in the Travel Health Notice and/or on the destination page.

Level 2: Practice Enhanced Precautions

Practice enhanced precautions for this destination. The Travel Health Notice describes additional precautions or defines a specific population at risk.

Level 3: Reconsider Nonessential Travel

Reconsider nonessential travel to this destination. The outbreak or event poses risk to travelers because limited precautions are available.

Level 4: Avoid All Travel

Avoid travel to this destination unless traveling for humanitarian aid or emergency response; there is an extreme health risk for travelers and no available precautions.

What Is Polio?

The World Health Organization (WHO) notes that it is a highly infectious disease caused by a virus that invades the nervous system and can cause total paralysis in matter of hours. The virus is transmitted by person to person spread mainly through the fecal-oral route, or less frequently, by a common vehicle, which could be either from contaminated food or water. The virus also multiplies in the intestine.

The National Institute of Health (NIH), US, notes that the virus responsible for causing Polio belongs to the Picornaviridae family.

As per the WHO, the common Polio symptoms are:

  • Fever
  • Fatigue
  • Headache
  • Vomiting
  • Stiffness of the neck a
  • Pain in the limbs

How Does Polio Spread?

Polio is mainly transmitted through the fecal-oral route, meaning it spreads when a person consumes food or water contaminated with the virus. It can also spread through close contact with an infected individual. The poliovirus lives in the throat and intestines of those infected, and poor sanitation, unsafe water, and inadequate hygiene greatly increase the risk of transmission, especially in communities with limited access to clean facilities.

In severe cases, polio can lead to acute flaccid paralysis, which may affect the diaphragm and throat muscles, making it difficult to breathe or swallow. Since there is no cure for polio, prevention remains the only line of defense. Raising awareness about polio vaccination is therefore essential to protect individuals, especially children, from this potentially life-threatening disease.

End of Article

Middle East Crisis Disrupting Health Services, Fueling Diseases & Environmental Hazards: WHO

Updated Mar 13, 2026 | 11:21 AM IST

SummarySince 28 February, the WHO verified 18 attacks on health care in Iran, which resulted in 8 deaths among health workers. During the same period, 25 attacks took place in Lebanon, resulting in 16 deaths and 29 injuries to health care workers.
Middle East Crisis Disrupting Health Services, Fueling Diseases & Environmental Hazards: WHO

Credit: MSF/X

The ongoing conflict in the Middle East, which has stretched to more than 10 days, is disrupting health services and fueling the risk of several infectious diseases as well as environmental hazards, the World Health Organization (WHO) has said.

Citing national health authorities, the WHO reported casualties:

  • Iran - over 1,300 died, 9,000 injured
  • Lebanon - 570 people died and more than 1,400 injured
  • Israel - 15 died and 2,142 injured.
In a statement, the WHO said it verified several attacks on health care workers since February 28. This has disrupted health facilities, leading to shortages of medicines, medical supplies, and fuel in hospitals.

These include:

  • Iran
- 18 attacks on healthcare facilities,

- 8 deaths among health workers

  • Lebanon
- 25 attacks on healthcare sites

- 16 deaths and 29 injuries to health care workers.

"The conflict is affecting the very services meant to save lives," the WHO said.

"These attacks not only cost lives but deprive communities of care when they need it most. Health workers, patients, and health facilities must always be protected under international humanitarian law,” it added.

Notably, the conflict is also collapsing health system with the shutdown of critical medical services:

  • Lebanon - 49 primary health care centers and 5 hospitals shut down.
  • Occupied Palestinian territory - ambulances and mobile clinics access delayed.
  • Gaza - medical evacuations suspended since 28 February
  • WHO’s global logistics hub in Dubai - disruption in movement of medical supplies

Francesca Quinto, Desk Manager at Doctors Without Borders, in an update social media platform X informed the threat to healthcare facilities in Lebanon.

"Our teams are witnessing the suffering up close: hospitals under pressure, communities repeatedly displaced and humanitarian needs rising sharply. Civilians and healthcare facilities must be protected and access to care and safety must be guaranteed," Quinto said.

The global health body also flagged wider public health risks due to the crisis, driving up disease risks among people displaced and living in shelter camps with limited access to safe water, sanitation, and hygiene.

As per current estimates, more than 100,000 people in Iran have relocated to other areas of the country due to insecurity, and up to 700,000 people have been internally displaced in Lebanon.

"These conditions increase the risk of respiratory infections, diarrheal diseases, and other communicable illnesses, especially for the most vulnerable populations, such as women and children," the WHO said.

Black Rain And Environmental Hazard

In addition, the Middle East crisis is also increasing concerns over environmental hazards. The petroleum fires and smoke from damaged infrastructure in Iran are potentially causing breathing problems, eye and skin irritation, and contaminated water and food sources.

Recently, Iran saw black rainfall after overnight Israeli strikes on several fuel depots caused fires to burn for hours.

Iran's Red Crescent Society had warned the residents of Tehran and the surrounding region that the rainfall after the strikes could be "highly dangerous and acidic", and could cause "chemical burns of the skin and serious damage to the lungs".

Call For De-escalation

The WHO called on all countries to de-escalate the conflict and "to protect civilians and health care, ensure unimpeded and sustained humanitarian access".

The WHO Director General, Tedros Adhanom Ghebreyesus, shared concerns about the rising global military expenditure and the rising world hunger rates.

"Global military expenditure just hit $2.7 trillion - in a single year. According to the UN estimates, ending world hunger by 2030 would require $93 billion annually. That means we spend almost 30 times more every year on killing each other than on making sure everyone eats. Numbers don't lie. Our priorities do," he said, in a post on social media platform X.

End of Article

Sleep Apnea Pill Could Be The Latest Breakthrough

Updated Mar 13, 2026 | 09:06 AM IST

SummaryA Phase II trial found the anti-seizure drug sultiame may improve obstructive sleep apnea symptoms and sleep quality. Researchers say the pill could offer a promising alternative for patients who struggle to tolerate CPAP machines.
Sleep Apnea Pill Could Be The Latest Breakthrough

Credits: Canva

About 30 to 83.7 million adults in the United States have Obstructive Sleep Apnea (OSA), notes American Lung Association. Roughly 80 per cent of these cases remain undiagnosed. However, now, a simple daily pill, an old drug, could just be the solution.

Scientists in Sweden and other places too, have been studying the anti-seizure medicine sultiame as a treatment for OSA. In their latest Phase II trial, the scientists found that people on sultiame experienced an improvement in their apsea symptoms, and their sleep quality too improved as compared to those taking placebo.

The results points towards the potential of sultiame becoming an effective option for people with sleep apnea, especially those who cannot tolerate continuous positive airway pressure (CPACP) machines. The findings are published in The Lancet, and the researchers noted: "These findings offer perspective for a pharmaceutical approach to treatment of patients with obstructive sleep apnea."

Sleep Apnea Pill: What Is This Condition?

OSA is the most common form of sleep apnea, and it happens when airway muscles physically block a person's breathing during sleep. This could pause the body to wake up enough to start breathing again, only for the cycle to restart throughout the night, anywhere from five to 100 times an hour. This also causes low oxygen levels and disturb people's sleep and, over time, can raise the risk of other long-term health problems, which could include heart diseases and even dementia.

What CPAP machines do is they use air pressure to keep the airways open during sleep. While machines are an effective way, some people have trouble using them long term, which is why some companies use less cumbersome interventions, including medicines.

Read: Harish Rana Case Highlights Why Planning For A Living Will Is Important

Sleep Apnea Pill: What Was It Used For?

Sultimae or sulthiame was first launched in the 1960s by Bayger AG as an anticonvulsant - which means, it was a drug designed to treat epilepsy and prevent seizures by stabilizing nerve cell membranes and reducing abnormal, excessive electrical activity in the brain.

What the drug does is, it inhibits carbonic anhydrase, an enzyme that plays a role in regulating our breathing. Research also suggested that this could help people with sleep apnea by preventing airway collapse. The US-based Apnimed, in collaboration with the Japenese company Shionogi & Co., Ltd., have been looking to develop sultiame as a sleep apnea treatment.

How Well Has The Sleep Apnea Pill Been Tested?

The phase II of the trial involved 298 patients. Of them were untreated, moderate and people with severe sleep apnea. The people were observed for over a 15-week period, of them, half were randomized to a placebo pill to be taken right before bed, while rest were given varying doses of sultiame.

The results showed that people who took sultiame saw a noticeable decrease in apnea symptoms and also witnessed improvements in their sleep quality and daytime sleepiness. People in the highest dose group saw the most improvement, with apnea symptoms being reduced up to 47 per cent.

“It feels like a breakthrough, and we now look forward to larger and longer studies to determine whether the effect is sustained over time and whether the treatment is safe for broader patient groups,” said study researcher Jan Hedner, a senior professor of pulmonary medicine at the University of Gothenburg.

End of Article